LX-2931

N/A

Report date: 2024/01/09 15:17:31
NME

Base Information

Drug NameLX-2931
Drug Alias NameLX-2931LX-3305LX 2931LX 3305ACB2003.4 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine-1-phosphate lyase 1 inhibitors
TargetsSphingosine-1-phosphate lyase 1
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLexicon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAC Bioscience LTDLexicon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A